Google
Trusted Resources: Community Center
Online support, community stories, financial assistance
Discoveries in CAEL-101 Trial for Patients With AL Amyloidosis
Jason Valent, MD, Director of the Multiple Myeloma Program and Co-Director of the Amyloidosis Program at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss the developments of the CAEL-101 trial for patients with AL amyloidosis. Listen as Dr. Valent talks about the discoveries and changes in treatment in each phase of the trial.
myBinderRelated Content
-
Nico Cheek-O’Donnell: Coping With Amyloidosis – ASG Webinar 4/6https://www.youtube.com/watch?v=CkBwTpXh...
-
Secondary, AA, AmyloidosisSecondary, AA, amyloidosis is a rare sys...
-
He Inherited A Devastating Disease. A CRISPR Gene-Editing Breakthrough Stopped ItPatrick Doherty had always been very act...
-
Heart Failure Diet: Sodium and Heart FailureHeart Failure Diet Resources and answer...
-
Gene Editing Therapy Paves Way for Revolution in Treatment of Genetic DisordersPeople with hereditary transthyretin (AT...
-
Right Ventricular Longitudinal Strain: A Tool for Diagnosis and Prognosis in Light-Chain AmyloidosisObjectives: Light-chain (AL) amyloidosi...
-
A Guide to Caring for a Loved one With Hereditary ATTR (hATTR) AmyloidosisWhen a family member has been diagnosed ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
